We believe that the consequences of COVID-19 will delay Faurecia SE's deleveraging prospects. We anticipate an 18%-22% revenue decline in 2020 and negative free operating cash flow of €400 million-€500 million this year, and only a gradual recovery in 2021, making it unlikely that the company will restore funds from operations (FFO) to debt above 30% and free operating cash flow (FOCF) to debt above 15% in the next 12-18 months. We are therefore lowering our long-term issuer credit rating on Faurecia to 'BB' from 'BB+'. The stable outlook reflects our belief that the company will gradually improve its credit metrics in 2021 such that FFO to debt and FOCF to debt will exceed 12% and 5%, respectively. Health and